Cited by 180Amyotrophic Lateral Sclerosis ResearchEpigenetics and DNA MethylationGenetic Neurodegenerative Diseases

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD

Open access

Liu, Elaine Y., Russ, Jenny, Wu, Kathryn, Neal, Donald, Suh, Eunran, McNally, Anna G., Irwin, David J., Van Deerlin, Vivianna M., Lee, Edward B.·2014·Acta Neuropathologica

DOI 10.1007/s00401-014-1286-yPMC PMC4161616

Open this paper in CoChat — free account

Abstract

Hexanucleotide repeat expansions of C9orf72 are the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal degeneration. The mutation is associated with reduced C9orf72 expression and the accumulation of potentially toxic RNA and protein aggregates. CpG methylation is known to protect the genome against unstable DNA elements and to stably silence inappropriate gene expression. Using bisulfite cloning and restriction enzyme-based methylation assays on DNA from human brain and peripheral blood, we observed CpG hypermethylation involving the C9orf72 promoter in cis to the repeat expansion mutation in approximately one-third of C9orf72 repeat expansion mutation carriers. Promoter hypermethylation of mutant C9orf72 was associated with transcriptional silencing of C9orf72 in patient-derived lymphoblast cell lines, resulting in reduced accumulation of intronic C9orf72 RNA and reduced numbers of RNA foci. Furthermore, demethylation of mutant C9orf72 with 5-aza-deoxycytidine resulted in increased vulnerability of mutant cells to oxidative and autophagic stress. Promoter hypermethylation of repeat expansion carriers was also associated with reduced accumulation of RNA foci and dipeptide repeat protein aggregates in human brains. These results indicate that C9orf72 promoter hypermethylation prevents downstream molecular aberrations associated with the hexanucleotide repeat expansion, suggesting that epigenetic silencing of the mutant C9orf72 allele may represent a protective counter-regulatory response to hexanucleotide repeat expansion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00401-014-1286-y

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 6×
“Both processes have been implicated in AlS and FTD [36, 37].”
Influential
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248
Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M.-S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., et al. (2014) · Nature · doi:10.1038/nature13124 · Cited by 978
Stress granules as crucibles of ALS pathogenesis
Li, Y. R., King, O. D., Shorter, J., & Gitler, A. D. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201302044 · Cited by 948
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Repeat instability: mechanisms of dynamic mutations
Pearson, C. E., Edamura, K. N., & Cleary, J. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1689 · Cited by 924 · cited 1×
“rANT aggregates have been proposed to be toxic [2, 46], perhaps through disruption of cellular pathways like autophagy or altered proteostasis [9, 50].”
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877

Show all 68 references

Sorted by citations

Items 101–180 of 180

Genomic and transcriptomic advances in amyotrophic lateral sclerosis
Rizzuti, M., Sali, L., Melzi, V., Scarcella, S., Costamagna, G., Ottoboni, L., Quetti, L., Brambilla, L., Papadimitriou, D. A., Verde, F., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102126 · Cited by 23
Sex-specific differences in genotoxic and epigenetic effects of 1,3-butadiene among mouse tissues
Lewis, L., Chappell, G. A., Kobets, T., O’Brian, B. E., Sangaraju, D., Kosyk, O., Bodnar, W. M., Tretyakova, N. Y., Pogribny, I. P., & Rusyn, I. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2374-x · Cited by 20
Repeat-associated non-AUG (RAN) translation mechanisms are running into focus for GGGGCC-repeat associated ALS/FTD
Goodman, L. D., & Bonini, N. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101697 · Cited by 20
The carboxyl termini of RAN translated GGGGCC nucleotide repeat expansions modulate toxicity in models of ALS/FTD
He, F., Flores, B. N., Krans, A., Frazer, M. A., Natla, S., Niraula, S., Adefioye, O., Barmada, S. J., & Todd, P. K. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01002-8 · Cited by 18
A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD
McCallister, T. X., Lim, C. K. W., Singh, M., Zhang, S., Ahsan, N. S., Terpstra, W. M., Xiong, A. Y., C., M. A. Z., Powell, J. E., Drnevich, J. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55548-5 · Cited by 19
Non-coding RNA in C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunction
Douglas, A. G. L. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.09.001 · Cited by 20
Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats
Dong, W., Zhang, L., Sun, C., Gao, X., Guan, F., Li, J., Chen, W., Ma, Y., & Zhang, L. (2020) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12129 · Cited by 18
Epigenetics in Neurodegenerative Diseases
van Zundert, B., & Montecino, M. A. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-75980-2_3 · Cited by 18
BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model
Quezada, E. R., Cappelli, C., Díaz, I. D. P., Jury, N., Wightman, N., Brown, R. H., Montecino, M. A., & van Zundert, B. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01039-z · Cited by 17
Modeling the C9ORF72 repeat expansion mutation using human induced pluripotent stem cells
Selvaraj, B. T., Livesey, M. R., & Chandran, S. (2017) · Brain Pathology · doi:10.1111/bpa.12520 · Cited by 14
Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases
Barbé, L., & Finkbeiner, S. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.750629 · Cited by 15
Targeted long-read sequencing to quantify methylation of the C9orf72 repeat expansion
Udine, E., Finch, N. A., DeJesus‐Hernandez, M., Jackson, J. L., Baker, M., Saravanaperumal, S. A., Wieben, E. D., Ebbert, M., Shah, J., Petrucelli, L., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00790-0 · Cited by 14
Methylation and Expression of Mutant FUS in Motor Neurons Differentiated From Induced Pluripotent Stem Cells From ALS Patients
Härtung, T., Rhein, M., Kalmbach, N., Thau‐Habermann, N., Naujock, M., Müschen, L. H., Frieling, H., Sterneckert, J. L., Hermann, A., Wegner, F., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.774751 · Cited by 16
CRISPR-Cas9 targeted deletion of the C9orf72 repeat expansion mutation corrects cellular phenotypes in patient-derived iPS cellsPreprint
Pribadi, M., Yang, Z., Kim, T. S., Swartz, E. W., Huang, A., Chen, J., Dokuru, D. R., Baek, J., Gao, F., Fua, A., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/051193 · Cited by 15
Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog
Langseth, A. J., Kim, J., Ugolino, J., Shah, Y., Hwang, H., Wang, J., Bergles, D. E., & Brown, S. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-05864-2 · Cited by 13
Epigenetic Small Molecules Rescue Nucleocytoplasmic Transport and DNA Damage Phenotypes in C9ORF72 ALS/FTD
Ramic, M., Andrade, N. S., Rybin, M. J., Esanov, R., Wahlestedt, C., Benatar, M. G., & Zeier, Z. R. (2021) · Brain Sciences · doi:10.3390/brainsci11111543 · Cited by 12
DNA hypermethylation of NOTCH2NLC in neuronal intranuclear inclusion disease: a case–control study
Cao, Y., Tian, W., Wu, J., Song, X., Cao, L. H., & Luan, X. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11272-y · Cited by 12
The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs
Robberecht, W., & Eykens, C. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s57397 · Cited by 14
A comparative bioinformatic analysis of C9orf72
Iyer, S., Acharya, K. R., & Subramanian, V. (2018) · PeerJ · doi:10.7717/peerj.4391 · Cited by 13
Distinct neurological disorders with C9orf72 mutations: genetics, pathogenesis, and therapy
Chi, S., Jiang, T., Tan, L., & Yu, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.033 · Cited by 12
Dipeptide repeat protein toxicity in frontotemporal lobar degeneration and in motor neurone disease associated with expansions in C9ORF72—a cautionary note
Mann, D. M. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.011 · Cited by 13
The Spectrum of Neurological and White Matter Changes and Premutation Status Categories of Older Male Carriers of the FMR1 Alleles Are Linked to Genetic (CGG and FMR1 mRNA) and Cellular Stress (AMPK) Markers
Loesch, D. Z., Trost, N. M., Bui, M., Hammersley, E., Lay, S. T., Annesley, S. J., Sanislav, O., Allan, C. Y., Tassone, F., Chen, Z.-P., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00531 · Cited by 11
Epigenetic regulatory modifications in genetic and sporadic frontotemporal dementia
Fenoglio, C., Scarpini, E. A., & Galimberti, D. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1481389 · Cited by 10
Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Hao, Z., Wang, R., Ren, H., & Wang, G. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00567-7 · Cited by 11
Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs
Gilbert, J. W., Kennedy, Z., Godinho, B. M. D. C., Summers, A., Weiss, A., Echeverria, D., Bramato, B. M., McHugh, N., Cooper, D., Yamada, K., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102291 · Cited by 8
Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells
Yanovsky‐Dagan, S. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i5.823 · Cited by 10
Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Calvo, B., Schembri-Wismayer, P., & Alonso, M. B. D. (2025) · Cells · doi:10.3390/cells14050347 · Cited by 9
Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies
Davidson, Y. S., Robinson, A., Rollinson, S. J., Pickering-Brown, S. M., Xiao, S., Robertson, J., & Mann, D. M. A. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1359304 · Cited by 8
Genetic and epigenetic disease modifiers in an Italian C9orf72 family expressing ALS, FTD or PD clinical phenotypes
Ratti, A., Peverelli, S., D’Adda, E., Colombrita, C., Gennuso, M., Prelle, A. C., & Silani, V. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1962355 · Cited by 8
Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia
Giannini, L. A. A., Boers, R., van der Ende, E. L., Poos, J. M., Jiskoot, L. C., Boers, J., van IJcken, W. F. J., Dopper, E. G. P., Pijnenburg, Y. A. L., Seelaar, H., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51997 · Cited by 8
From Environment to Gene Expression: Epigenetic Methylations and One-Carbon Metabolism in Amyotrophic Lateral Sclerosis
Hernán-Godoy, M., & Rouaux, C. (2024) · Cells · doi:10.3390/cells13110967 · Cited by 8
Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
Liu, E. Y., Russ, J., & Lee, E. B. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-2911 · Cited by 7
Self-citation
Characterization of C9orf72 haplotypes to evaluate the effects of normal and pathological variations on its expression and splicing
Ben‐Dor, I., Pacut, C. M., Nevo, Y., Feldman, E. L., & Reubinoff, B. E. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009445 · Cited by 6
The effects of molecular crowding and CpG hypermethylation on DNA G-quadruplexes formed by the C9orf72 nucleotide repeat expansion
Ozcan, K. A., Ghaffari, L., & Haeusler, A. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-02041-4 · Cited by 8
DNA Methylation Profiles of PSMA6, PSMB5, KEAP1, and HIF1A Genes in Patients with Type 1 Diabetes and Diabetic Retinopathy
Svikle, Z., Paramonova, N., Siliņš, E., Pahirko, L., Zariņa, L., Baumane, K., Petrovski, G., & Sokolovska, J. (2024) · Biomedicines · doi:10.3390/biomedicines12061354 · Cited by 7
The role of cytosine methylation in regulating the topology and liquid–liquid phase separation of DNA G-quadruplexes
Tsuruta, M., Shil, S., Taniguchi, S., Kawauchi, K., & Miyoshi, D. (2025) · Chemical Science · doi:10.1039/d4sc06959e · Cited by 6
DNA Methylation in Neuronal Development and Disease
Bruggeman, E. C., & Yao, B. (2019) · RNA technologies · doi:10.1007/978-3-030-14792-1_5 · Cited by 7
DNA methylation slows effects of C9orf72 mutations
Day, J. J., & Roberson, E. D. (2015) · Neurology · doi:10.1212/wnl.0000000000001504 · Cited by 6
The shared ancestry between the C9orf72 hexanucleotide repeat expansion and intermediate-length alleles using haplotype sharing trees and HAPTK
Rautila, O. S., Kaivola, K., Rautila, H., Hokkanen, L., Launes, J., Strandberg, T. E., Laaksovirta, H., Palmio, J., & Tienari, P. J. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.12.019 · Cited by 5
DNA Methylation in Neurodegenerative Diseases
Fedotova, E. Y., & Illarioshkin, S. N. (2019) · Russian Journal of Genetics · doi:10.1134/s1022795419030062 · Cited by 5
The implications of DNA methylation for amyotrophic lateral sclerosis
Reis, A. H. D. O., Figalo, L. B., Orsini, M. A., & Lemos, B. (2023) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202320230277 · Cited by 6
Quadruplex targets in neurodegenerative diseases
Plavec, J. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.05.003 · Cited by 6
An Epigenetic Spin to ALS and FTD
Ebbert, M., Lank, R. J., & Belzil, V. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_1 · Cited by 5
Frontotemporal dementia
Wauters, E., Sleegers, K., Cruts, M., & Broeckhoven, C. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00009-9 · Cited by 6
Correction of Heritable Epigenetic Defects Using Editing Tools
Handal, T., & Eiges, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083966 · Cited by 5
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism
Vaughan, D. P., Real, R., Jensen, M. T., Fumi, R., Hodgson, M., Jabbari, E., Lux, D., Wu, L., MD-GAP, Warner, T. T., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12990-9 · Cited by 4
DNA methylation as a contributor to dysregulation of STX6 and other frontotemporal Lobar degeneration genetic risk-associated loci
Rambarack, N., Fodder, K., Murthy, M. N., Toomey, C. E., de Silva, R., Heutink, P., Humphrey, J., Raj, T., Lashley, T., & Bettencourt, C. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02071-3 · Cited by 3
Genetics of frontotemporal dementia
Gökalp, E. E., Adapınar, D. Ö., & Artan, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817990-1.00001-9 · Cited by 2
Genome-Wide DNA Methylation in Early-Onset-Dementia Patients Brain Tissue and Lymphoblastoid Cell Lines
Ramos‐Campoy, O., Comas‐Albertí, A., Hervás, D., Borrego‐Écija, S., Bosch, B., Sandoval, J., Fort‐Aznar, L., Moreno, F., Fernández‐Villullas, G., Molina‐Porcel, L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105445 · Cited by 2
Neurodegenerative Diseases and Autophagy
Fleming, A., Vicinanza, M., Renna, M., Puri, C., Ricketts, T., Füllgrabe, J., López, A., de Jager, S. M., Ashkenazi, A., Tanasa, M. P., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00011-0 · Cited by 2
Evaluation of methylation status of the 5’-promoter region of C9orf72 gene in Russian patients with neurodegenerative diseases
Shpilyukova, Y. A., Fedotova, E. Y., Погода, Т. В., Abramycheva, N. Y., Vetchinova, A. S., Zakharova, M. N., & Illarioshkin, S. N. (2018) · Neuromuscular Diseases · doi:10.17650/2222-8721-2018-8-2-33-41 · Cited by 2
Frontotemporal lobar degeneration
Kim, B., Viera-Ortiz, A., Phan, J. M., Irwin, D. J., & Lee, E. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00041-1 · Cited by 3
Self-citation
Epigenetic regulations in neurological disorders
Mondal, P., Sarkar, S., & Das, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00010-4 · Cited by 2
Zebrafish C9orf72 loss-of-function models of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Rounding, N. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 2
Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repairPreprint
Ababneh, N. A., Scaber, J., Flynn, R., Douglas, A. G. L., Turner, M. R., Sims, D., Dafinca, R., Cowley, S. A., & Talbot, K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.17.864520 · Cited by 3
Evidence for a Growing Involvement of Glia in Amyotrophic Lateral Sclerosis
Radford, R. A. W., Vidal-Itriago, A., Scherer, N. M., Lee, A., Graeber, M. B., Chung, R. S., & Morsch, M. (2021) · Wiley eBooks · doi:10.1002/9781119745532.ch7 · Cited by 3
The epigenetics of neurodegenerative diseases
Coppedè, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18661-5.00001-4 · Cited by 1
Accurate DNA methylation predictor for C9orf72 repeat expansion alleles in the pathogenic range
Ramesh, N., Evans, A., Wojta, K. J., Yang, Z., Boks, M. P., Kahn, R. S., de Boer, S. C. M., van der Lee, S. J., Pijnenburg, Y. A. L., Reus, L. M., et al. (2025) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2025.100522 · Cited by 1
DNA Modifications and Memory
Day, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801596-4.00006-x · Cited by 1
Repairing the Epigenetics of Unstable Repeats by Genome EngineeringPreprint
Handal, T., & Eiges, R. (2021) · Preprints.org · doi:10.20944/preprints202103.0291.v1
Genetic Basis of ALS
Ross, J. P., Dion, P. A., & Rouleau, G. A. (2021) · Wiley eBooks · doi:10.1002/9781119745532.ch2 · Cited by 1
DNA methylation as a contributor to dysregulation of STX6 and other frontotemporal lobar degeneration genetic risk-associated lociPreprint
Rambarack, N., Fodder, K., Murthy, M. N., Toomey, C. E., de Silva, R., Heutink, P., Humphrey, J., Raj, T., Lashley, T., & Bettencourt, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.21.634065 · Cited by 1
Thalamic volume as a susceptibility/risk biomarker for C9orf72 phenoconversionPreprint
Shen, T., Wuu, J., Olm, C. A., Radhakrishnan, H., Li, Y., Pattany, P. M., Granit, V., Carberry, N., Irwin, D. J., Massimo, L. M., et al. (2025) · medRxiv · doi:10.1101/2025.09.20.25336234 · Cited by 1
Self-citation
neuroprotective and neuropathologic evidence
McMillan, C. T., Russ, J., Wood, E. M., Irwin, D. J., Grossman, M., McCluskey, L. F., Elman, L. B., Deerlin, V. M. V., & Lee, E. B. (2015)
Self-citation
The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs
Leuven, K. (2015)
A survey of axonal transport function and motor behaviour in Drosophila models of amyotrophic lateral sclerosis
Baldwin, K. R. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Redox Regulation and Misfolding of SOD1: Therapeutic Strategies for Amyotrophic Lateral Sclerosis
Hubens, W. H. G., & Okado‐Matsumoto, A. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-30705-3_27
Structural and dynamics study of G-rich sequences relevant to genomic disorders
Maity, A. (2020) · doi:10.32657/10356/141701
Unraveling molecular biology of C9ORF72 repeat expansions in amyotrophic lateral sclerosis-frontotemporal dementia: Implications for therapy
Arogundade, O. A., Jiang, J., & Ravits, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00009-4
Distribuição celular e função da proteína C9ORF72 em modelos celulares de Esclerose Lateral Amiotrófica
Reis, J. A. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2020.tde-09112020-111224
The Impact of Familial ALS-Associated Mutations on Astrocyte Activation under Serum and Serum-Free Conditions
Jones, A. S. (2023) · doi:10.14418/wes01.1.2796
Antisense oligonucleotide targeting pathogenic sense repeat RNA in C9ORF72 suppresses production of antisense-dependent dipeptide repeat proteins implicated in ALS/FTDPreprint
Gu, Y., Kankel, M. W., Watts, J. K., Jafar‐Nejad, P., & Almeida, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.04.616663
Biomarkers for Proteostasis Disruption: An Overview
Prakash, D., & Bisht, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_8
Additional file 1 of BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model
Quezada, E. R., Cappelli, C., Díaz, I. D. P., Jury, N., Wightman, N., Brown, R. H., Montecino, M. A., & van Zundert, B. (2021) · Figshare · doi:10.6084/m9.figshare.14227789
Modeling C9ORF72 loss-of-function : a knockdown mouse model
Lopez-Herdoiza, M.-B. (2016) · theses.fr (ABES) · doi:10.70675/dfc77570z827az4993z840dz21dfc54360de
Analyses génétiques et fonctionnelles de nouveaux gènes incriminés dans la Sclérose Latérale Amyotrophique (SLA)
Teyssou, E. (2017) · theses.fr (ABES) · doi:10.70675/6b2c9ef9z3766z4be8z8030zea731dbce4f3
AUG-Dependent Translation of Antisense Repeat Transcripts Contributes to Dipeptide Repeat Protein Production in C9ORF72 Expansion Carriers
Almeida, S., Gu, Y., & Kankel, M. W. (2026) · Cells · doi:10.3390/cells15181701
Identity-by-descent to resolve reduced penetrance and advance gene discovery in neurodegenerative disease
Henden, L., Fat, S. C. M., Smith, A., Li, I., Nicholas, T. J., Mrkela, M., O'Shaughnessy, D., Zussa, Z. N., Grima, N., McCann, E. P., et al. (2026) · Brain · doi:10.1093/brain/awag326
TDP-43 and ALS - what's wrong with my membranes?
Dahlhaus, R., Yalcin, I., Tischer, J., & Braun, R. J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107630
DNA methylation in motor neuron biology and epigeneticopathy in amyotrophic lateral sclerosis
MARTIN, L. J. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19043-8.00014-1

Authors: Liu, E. Y., Russ, J., Wu, K., Neal, D., Suh, E., McNally, A. G., Irwin, D. J., Van Deerlin, V. M., & Lee, E. B.
Affiliations: University of Pennsylvania (US)
Corresponding author: Lee, Edward B.
ORCID: Russ, Jenny
Wu, Kathryn
Suh, Eunran
McNally, Anna G.
Irwin, David J.
Lee, Edward B.
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2014-05-08
Volume: 128
Issue: 4
Pages: 525-541
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-014-1286-y
PMC: PMC4161616
OpenAlex: W1982725145
Cited by: 180
References: 68
Citations by year: 2026: 4 · 2025: 10 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 17 · 2020: 15 · 2019: 17 · 2018: 19 · 2017: 20 · 2016: 19 · 2015: 30 · 2014: 7
FWCI: 16.52
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Centers for Disease Control and Prevention (ND14442, ND11836, ND16183, ND10966)
National Institute on Aging (P30AG10125, T32 AG 00255, P30AG010124, P01AG017586, K08AG039510, P01AG032953, T32AG000255)
National Institute of Neurological Disorders and Stroke (K23NS088341)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords: C9orf72, hexanucleotide repeat expansion, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, CpG hypermethylation, promoter hypermethylation, epigenetic silencing, RNA foci, oxidative stress
MeSH terms: C9orf72 Protein, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Analysis of Variance, Cell Line, Transformed, DNA Mutational Analysis, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Mutation, Promoter Regions, Genetic, Proteins, RNA, Messenger, CpG Islands, DNA Methylation, DNA Repeat Expansion, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks